1. Home
  2. RFL vs PLUR Comparison

RFL vs PLUR Comparison

Compare RFL & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • PLUR
  • Stock Information
  • Founded
  • RFL 2017
  • PLUR 2001
  • Country
  • RFL United States
  • PLUR Israel
  • Employees
  • RFL N/A
  • PLUR N/A
  • Industry
  • RFL Real Estate
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RFL Finance
  • PLUR Health Care
  • Exchange
  • RFL Nasdaq
  • PLUR Nasdaq
  • Market Cap
  • RFL 48.4M
  • PLUR 41.9M
  • IPO Year
  • RFL N/A
  • PLUR N/A
  • Fundamental
  • Price
  • RFL $1.66
  • PLUR $5.19
  • Analyst Decision
  • RFL
  • PLUR Strong Buy
  • Analyst Count
  • RFL 0
  • PLUR 1
  • Target Price
  • RFL N/A
  • PLUR $12.00
  • AVG Volume (30 Days)
  • RFL 450.8K
  • PLUR 60.5K
  • Earning Date
  • RFL 06-11-2025
  • PLUR 05-13-2025
  • Dividend Yield
  • RFL N/A
  • PLUR N/A
  • EPS Growth
  • RFL N/A
  • PLUR N/A
  • EPS
  • RFL N/A
  • PLUR N/A
  • Revenue
  • RFL $732,000.00
  • PLUR $1,034,000.00
  • Revenue This Year
  • RFL N/A
  • PLUR $472.39
  • Revenue Next Year
  • RFL N/A
  • PLUR $254.29
  • P/E Ratio
  • RFL N/A
  • PLUR N/A
  • Revenue Growth
  • RFL 35.56
  • PLUR 203.23
  • 52 Week Low
  • RFL $1.27
  • PLUR $3.33
  • 52 Week High
  • RFL $3.19
  • PLUR $7.13
  • Technical
  • Relative Strength Index (RSI)
  • RFL 46.95
  • PLUR 60.04
  • Support Level
  • RFL $1.41
  • PLUR $4.11
  • Resistance Level
  • RFL $1.70
  • PLUR $5.40
  • Average True Range (ATR)
  • RFL 0.28
  • PLUR 0.55
  • MACD
  • RFL -0.05
  • PLUR 0.11
  • Stochastic Oscillator
  • RFL 11.63
  • PLUR 86.27

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.

Share on Social Networks: